Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000675089 | SCV000800607 | uncertain significance | Peroxisome biogenesis disorder 6A (Zellweger); Peroxisome biogenesis disorder 6B | 2017-10-18 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000728635 | SCV000856235 | uncertain significance | not provided | 2017-08-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001246837 | SCV001420224 | likely pathogenic | Peroxisome biogenesis disorder, complementation group 7 | 2024-06-22 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 331 of the PEX10 protein (p.Arg331Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with Zellweger Syndrome Spectrum (PMID: 20695019, 27230853). It has also been observed to segregate with disease in related individuals. This variant is also known as c.932G>A, p.Arg311Gln. ClinVar contains an entry for this variant (Variation ID: 162433). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV003474800 | SCV004201405 | pathogenic | Peroxisome biogenesis disorder 6A (Zellweger) | 2024-03-02 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000675089 | SCV005641504 | likely pathogenic | Peroxisome biogenesis disorder 6A (Zellweger); Peroxisome biogenesis disorder 6B | 2024-05-29 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000149811 | SCV000196635 | pathogenic | Peroxisome biogenesis disorder 6B | 2010-08-01 | no assertion criteria provided | literature only |